For adults with acute myeloid leukemia (AML), pretransplant NPM1 measurable residual disease (MRD) is prognostic for relapse, ...

Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today ...

First Interim Unblinding of Pivotal AML Trial Now Imminent - Potentially the Most Important Data Moment in Company ...

Across treatment classes, CH associated with increased therapy-related cytopenias, particularly neutropenia, and DNMT3A/TET2 ...

Disease characteristics, age, and geography are among the main factors that shape first-line treatment patterns in patients ...

Severe CRS appeared numerically less frequent than in ZUMA-3, suggesting potential differences in patient selection, ...

Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has ...

Scarpetta makes a bold move when it comes to their titular character's backstory. If you have read Patricia Cornwell’s novels ...

Follow Layla’s inspiring journey as music becomes her source of strength and comfort while battling leukemia. See how melody, rhythm, and creativity bring hope, courage, and joy to her fight.

Here are five tests worth asking your doctor about at your next visit. The complete blood count, or CBC, measures red blood ...

The newest, youngest member of the Las Vegas Metropolitan Police Department put on her pink mirrored sunglasses and walked to ...

Miracle Trial Preliminary Blinded CRc Rate of 40% in First 30 Patients Suggests Encouraging Early Results in ...